Clinical Trial Update: Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer

View source ↗

Summary

Completed clinical trial evaluating feasibility, evaluability, and variability in markers of drug action in metastatic castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Metastatic Castration Resistant Prostate Cancer | Status: COMPLETED